Search

everythinglearnresearchcommunity

for

Search:↓

The new drug carriers show promise for better targeting and treating ovarian cancer.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

PCOS and related metabolic issues often run in families.

Yoga Nidra improves well-being and reduces anxiety in women with PCOS.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Late onset of first period and irregular development of sexual traits in teenage girls can lead to poorer reproductive health.

Homeopathic medicine was found effective for treating polycystic ovarian syndrome.

CAM practitioners in the eThekwini area are exploring ways to manage and diagnose Polycystic Ovarian Syndrome.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Women with PCOS often have acne, obesity, and excess hair, especially on the chin and upper lip.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

STK11 gene polymorphism does not predict metformin response in PCOS.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Acupressure improves quality of life in PCOS patients.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.